Overview
GLMD market data
Price History
GLMD price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for GLMD. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving PremarketBenzinga · Jul 21, 2026, 9:11 AM
Galmed Pharmaceuticals shares are trading higher after the company announced the development of a new Aramchol-based lipid nanoparticles formulation for targeted delivery to the heart.Benzinga · Jul 16, 2026, 6:00 PM
Galmed Pharmaceuticals Announces Breakthrough Development Of New Aramchol-Based Lipid Nanoparticles Formulation For Targeted Delivery To The HeartBenzinga · Jul 16, 2026, 11:35 AM
Galmed Pharmaceuticals Has Received A Notice Of Allowance For A U.S. Patent Titled "TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS"Benzinga · Jul 1, 2026, 8:05 PM
Galmed Agrees With Acquisition Target Colospan To Increase The Cash Portion Of Purchase Price By $800K In Lieu Of Issuing $2M In SharesBenzinga · Jun 22, 2026, 11:35 AM
Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion MarketBenzinga · Jun 8, 2026, 1:15 PM
Galmed Pharmaceuticals Signs Agreement To Acquire Medical Device Firm Colospan For $2.5M In Cash, $2M Galmed SharesBenzinga · Jun 8, 2026, 12:20 PM
UK's MHRA Says Resmetirom (Rezdiffra) Authorized To Treat Metabolic Dysfunction-Associated Steatohepatitis In AdultsBenzinga · Jun 3, 2026, 3:35 PM
Galmed Reports Preclinical Results for Heart Disease Drug Combination, Study Identifies New Pathway Linked to Cardiac FibrosisBenzinga · Jun 2, 2026, 11:38 AM
Galmed Pharmaceuticals shares are trading higher after the company announced milestone results from a Phase 1 PK study in healthy subjects.Benzinga · May 14, 2026, 4:23 PM